PTP4A3 and breast carcinoma: A DNA vaccine targeting PTP4A3 triggered high expression of interferon-γ and TNF-α in breast cancer through the CTL and T helper type 1 cells immune response and also stimulated the accumulation of PTP4A3 antibody in immunized mice (29).